Clinical Trial Update: Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the use of antithrombin concentrate (Thrombate III) in patients undergoing cardiac surgery with cardiopulmonary bypass, including those …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Antithrombin Iii Deficiency
• Coronary Artery Disease

Drugs mentioned

• Thrombate III (antithrombin III concentrate)

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Acquired Antithrombin III Deficiency, Coronary Artery Bypass | Phase 2 | Status: COMPLETED | Results posted: 2016-08-04